Menu
Log in

FCACC logo

2025 continuing education credit


annual meeting banner

Criteria for Success

Certificates of completion will be awarded based on the participant's attendance.  A certificate of completion will be available upon completion of an online evaluation/claim credit form available at:

 

 

Please claim your credit by 8/30/2025.

 

If you have questions about this CE activity, please contact AKH Inc at JGoldman@akhcme.com.



Annual Meeting of the Florida Chapter ACC

Where Science Meets Patient Care

August 1 - 3, 2025 | Lake Buena Vista, FL

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare. 


In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and the Florida Chapter, American College of Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Nurses

Credit being awarded: 7.0 ANCC contact hours

 

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 7.0 contact hours.

 

Physician Associates

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 7.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 


Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and the Florida Chapter, American College of Cardiology.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 7.0 contact hour(s) (which includes 3.5 hour(s) of pharmacology).

 

Commercial Support

There is no commercial support for this activity.


Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

 

DISCLOSURES

Name

Relationship

Commercial Interest

Demilade A. Adedinsewo, M.B., Ch.B., FACC (faculty)

N/A

Nothing to disclose

Sadeer Al-Kindi, MD, FACC (faculty)

N/A

Nothing to disclose

Carlos Alfonso, MD, FACC (moderator)

Speaker

Johnson & Johnson (Shockwave Medical)

Shone Almeida, MD, FACC (moderator)

Speaker

Heartflow, Inc

Carlos L. Alviar MD, FACC FESC (faculty)

Consultant

4TEEN4; Abbott; JNJ Medtech; Zoll

 

Researcher

Baxter

Shawn Anderson, PharmD (panelist)

N/A

Nothing to disclose

Shantelle Bartra, APRN, AACC (panelist)

N/A

Nothing to disclose

Thomas M. Beaver, MD, MPH (faculty)

Researcher

Abbott; Edwards Lifesciences; Medtronic

 

Speaker

Edwards Lifesciences

Katelyn Bruno, PhD, FHFSA, FACC (moderator)

N/A

Nothing to disclose

Edward Chu, MD, FACC (panelist)

N/A

Nothing to disclose

Madhavi Chunduru, MD, FACC (faculty)

N/A

Nothing to disclose

Jennifer Co-Vu, MD, FACC (moderator)

N/A

Nothing to disclose

Kenneth Coca, MD (faculty)

N/A

Nothing to disclose

Daniela Crousillat, MD, FACC (faculty)

Consultant

Heartflow, Inc

Elizabeth H. Dineen, DO, FACC (faculty)

N/A

Nothing to disclose

Sophia Eikenberry (faculty)

N/A

Nothing to disclose

Abdallah El Sabbagh, MD (faculty)

N/A

Nothing to disclose

DeLisa Fairweather, PhD (faculty)

N/A

Nothing to disclose

Jason Findlay, MD (faculty)

N/A

Nothing to disclose

Kara Gay-Simon, MD (faculty)

N/A

Nothing to disclose

Elliot Griffith, MD (faculty)

N/A

Nothing to disclose

Michelle Gumz, PhD (faculty)

N/A

Nothing to disclose

Nadira Hamid, MD (faculty)

Consultant

4C Medical Technologies; Abbott Structural; Adona; Alleviant Medical; AMX; CroiValve; Edwards Lifesciences, GE; Laza Medical; Philips; Siemens; Valcare Med Ltd; Vdyne; WL Gore

Dipti Itchhaporia, MD, MACC, FAHA, FESC, FRCP (faculty)

N/A

Nothing to disclose

Krithika Krishnarao, DO, FACC (faculty)

N/A

Nothing to disclose

Fred Kusumoto, MD, FACC (faculty)

N/A

Nothing to disclose

Roberta M. Lassance-Soares, PhD (faculty)

N/A

Nothing to disclose

Grace Lin, MD, MBA, FACC, FASE (faculty)

N/A

Nothing to disclose

JoAnn Lindenfeld, MD, FACC (faculty)

Consultant

Abbott; Adona; Alleviant; Axon; Boston Scientific; CVRx; Edwards Lifesciences; Intershunt; Medtronic; Merck; Orchestra; Pulnova; Vascular Dynamics; VWave

Jose Lopez Batista, MD (faculty)

N/A

Nothing to disclose

Melissa Lyle, MD, FACC (program director; moderator)

N/A

Nothing to disclose

Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC (faculty)

Consultant

Arrowhead; Bayer; Boehringer Ingelheim; Edwards Lifesciences; Ionis; Eli Lilly; Merck; New Amsterdam; Novartis; Novo Nordisk

Catherine Nadeau DNP, PhD, APRN, FNP-BC, CNE (faculty)

N/A

Nothing to disclose

Jose Nativi, MD, MS, FACC (faculty)

Researcher

Alnylam; Alexion/AztraZeneca; Intellia

Viviana Navas, MD (faculty)

Speaker

Alnylam; Boehringer Ingelheim; Pfizer; SC Pharmaceuticals

Alex Nusbickel, MD (faculty)

N/A

Nothing to disclose

Chinedu Nwabuobi, MD, MS (faculty)

N/A

Nothing to disclose

Alex Parker, MD (faculty; moderator)

N/A

Nothing to disclose

Dana Penfold, DO (faculty)

N/A

Nothing to disclose

Keniel Pierre, MD (faculty)

N/A

Nothing to disclose

Simon Pinsky, DO (faculty)

N/A

Nothing to disclose

Chris Jordan Ray, MD, FACC (faculty)

N/A

Nothing to disclose

Alex P. Rodriguez, MD, FACC, FSCMR (faculty)

N/A

Nothing to disclose

Rachel Roedding, DNP, FNP-BC, APRN (faculty)

N/A

Nothing to disclose

Josh Saef, MD, FACC (panelist)

N/A

Nothing to disclose

Arwa Saidi, MB. BCh. M. Ed., FACC (panelist)

N/A

Nothing to disclose

Rhea Sancassani, MD, FACC (faculty)

N/A

Nothing to disclose

Alexandra Sarau, MD (faculty)

N/A

Nothing to disclose

Naushad Shaik, MD, FACC, FHRS, CCDS (panelist)

Consultant; Speaker

Abbott; Biosense Webster; Biotronik; Boston Scientific; Medtronic

Joel Shoemaker, MMS, PA-C (faculty)

N/A

Nothing to disclose

David Snipelisky, MD, FACC (faculty)

N/A

Nothing to disclose

Kevin Tayon, MD (faculty)

N/A

Nothing to disclose

Ufuk Vardar, MD (faculty)

N/A

Nothing to disclose

Alex Velasquez, MD (moderator)

N/A

Nothing to disclose

Jeffrey Williams, MD, FACC (moderator)

Consultant

Alta Thera Corp.; Boston Scientific

Robby Wu, DO, FACC (faculty)

Speaker

Bristol Myers Squibb

Dorothy Caputo, MA, BSN, RN – President, AKH Inc

N/A

Nothing to disclose

Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer)

N/A

Nothing to disclose

Dorothy Duffy, RPh (planner/reviewer)

N/A

Nothing to disclose

Michele Bielarski, RN (planner/reviewer)

N/A

Nothing to disclose

AKH Inc Staff and Planners

N/A

Nothing to disclose

FL ACC Staff and Planners

N/A

Nothing to disclose

All of the relevant financial relationships listed for these individuals have been mitigated.

 

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

 

If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.


Activity Overview

The cardiovascular team is an intricate part of any successful CV care setting, care givers must be up to date on the latest therapies and technologies.

 

Target Audience

This activity is designed for an audience of physicians, nurses, pharmacists, physician associates and nurse practitioners who treat and manage cardiovascular diseases.

 

Learning Objectives

Upon completion of the educational activity, participants should be able to:

Heart of the Game: Updates in the World of Sports Cardiology

  • Evaluate recent advancements in sports cardiology and their implications for athlete care.

Baroreflex Activation Therapy in Heart Failure

  • Explain the clinical rationale and therapeutic role of baroreflex activation therapy in managing heart failure.

From Forgotten to Frontline: Managing Tricuspid Regurgitation

  • Differentiate between surgical and percutaneous approaches for managing tricuspid regurgitation using current imaging, device options, and lead-related considerations.

The Irwin R. Callen, MD Memorial Lectureship: Disease-Modifying Treatments for ATTR Amyloidosis

  • Compare available disease-modifying treatments for ATTR amyloidosis and their clinical applications.

Revolutionizing Heart Health: The Power of AI in Cardiovascular Care

  • Analyze how artificial intelligence is transforming cardiovascular diagnosis, treatment planning, and patient outcomes.

Climate Change and Environmental Exposures: Effect on Cardiovascular Health

  • Assess the cardiovascular risks associated with climate change and environmental exposures.

Shocking Advances: The Latest Updates in Cardiogenic Shock Management

  • Identify and apply recent innovations and guideline updates in the management of cardiogenic shock.

Imaging for Ischemia: What Modality is Best?

  • Compare diagnostic imaging modalities for ischemia and determine the most appropriate option based on clinical context.

Cardiology Critical Care & Cardiogenic Shock Management

  • Implement expert consensus recommendations and advanced interventions—including PAC use and ECMO—for managing cardiogenic shock.

Cardio-Obstetrics

  • Design and optimize multidisciplinary cardio-obstetric care models using predictive tools, GDMT, and emerging AI strategies.

Challenges in ACHD Management

  • Evaluate complex case-based approaches to managing congenital heart disease in adults, including Turner syndrome, Tetralogy of Fallot, and transposition of the great arteries.

EP Summit

  • Summarize emerging strategies and technologies in electrophysiology for arrhythmia management.

Controversies in the Management of Amyloidosis

  • Debate current treatment controversies in cardiac amyloidosis, including the role of LAA occlusion, TTR therapies, and heart transplantation.

Translational Research

  • Discuss the impact of novel translational cardiovascular research on clinical care, with an emphasis on hypertension, autoimmune disease, and ischemia.

Women Cardiologists

  • Examine the evolving contributions and leadership roles of women in cardiology and strategies to enhance representation.

Cardiovascular Disease and Obesity

  • Explore advancements in the management of obesity and its cardiovascular implications.

Percutaneous Mechanical Aspiration in Infective Endocarditis

  • Describe the indications, technique, and outcomes of percutaneous mechanical aspiration for the treatment of infective endocarditis.

FL-QUIC Oral Presentations

  • Evaluate innovative quality improvement initiatives in postpartum cardiovascular care and radiation dose optimization in CCTA programs.

FIT Oral Olympics

  • Interpret findings from recent clinical trials in electrophysiology and valvular interventions, including pacing strategies, valve replacement, and anticoagulation approaches.

 

Criteria for Success

Certificates of completion will be awarded based on the participant's attendance.  A certificate of completion will be available upon completion of an online evaluation/claim credit form available at:

 

akhcme.com/FLACC

 

Please claim your credit by 8/30/2025.

 

If you have questions about this CE activity, please contact AKH Inc at JGoldman@akhcme.com.

 


 






Florida Chapter, American College of Cardiology
3208 E. Colonial Drive, Suite 264

Orlando, FL 32803

Contact Us



Powered by Wild Apricot Membership Software